NUS medical school developing Covid-19 vaccine with Monash University
Researchers from the National University of Singapore (NUS) and Monash University in Australia are developing a Covid-19 vaccine that could be ready for clinical trials by the end of next year.
The vaccine, modified from a cancer drug, has undergone animal studies, and researchers are hoping to conduct clinical trials in Singapore and Australia.
Called Clec9A-RBD, it is the third coronavirus vaccine that Singapore is involved in developing.
Copying/Pasting full or partial texts with adding very little original content is frowned upon by the community. Repeated copy/paste posts could be considered spam. Spam is discouraged by the community and may result in the account being Blacklisted.